We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide
Product News

AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide

AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide
Product News

AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "AnaSpec Introduces MOG (35-55), Mouse, Rat Peptide"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AnaSpec support advances in MS research by providing MOG (35 - 55), mouse, rat, a key peptide that induces severe chronic experimental autoimmune encephalomyelitis in transgenic mice.

AnaSpec’s MOG (35-55) peptide from mouse and rat sequence (cat# 60130) has been shown to induce anti-MOG (35-55) autoantibody production in C57BL/6 mice at 100% incidence (10/10), indicating that this peptide is the clear choice for in vivo anti-MOG (35-55) autoantibody study.

In addition to this peptide, AnaSpec also provides a large selection of MOG peptides of varied sequences and lengths, and MBP (myelin basic protein) and PLP (proteolipid proteins) peptides, two other potential primary encephalitogenic target antigens in multiple sclerosis.

Advertisement